2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Cartilage Diseases: new trials by email Literature Review of Cartilage Diseases trials Research Report on Cartilage Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis Rituximab, Infliximab, Tocilizumab - Giant Cell Arteritis, Takayasu Arteritis | Phase 2 | Terminated | Cambridge University Hospitals NHS Foundation Trust | 22 | 2021-07-14 | 2025-06-17 |
| Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia Famotidine, Speech Language Therapy - Laryngomalacia, Gastro Esophageal Reflux | Phase 1 / Phase 2 | Terminated | Reema Padia | 65 | 2020-11-18 | 2025-07-20 |
Cogan Syndrome (1) · Communication Disorders (1) · Cryoglobulinemia, Familial Mixed (1) · Gastroesophageal Reflux (1) · Giant Cell Arteritis (1) · IgA Vasculitis (1) · Laryngomalacia (1) · Polyarteritis Nodosa (1) · Polychondritis, Relapsing (1) · Takayasu Arteritis (1) · Vasculitis (1)
Connective Tissue Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Skin and Connective Tissue Diseases (2) · Aortic Arch Syndromes (1) · Aortic Diseases (1) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Blood Coagulation Disorders (1) · Brain Diseases (1) · Cardiovascular Diseases (1)
Famotidine (1) · Infliximab (1) · Rituximab (1) · Speech Therapy (1) · tocilizumab (1)
Cambridge University Hospitals NHS Foundation Trust (1) · Reema Padia (1)
United Kingdom (1) · United States (1)
David Jayne (1) · Reema Padia, MD (1)